FEATURING
- We are thrilled to welcome you back to Washington DC for the in-person/hybrid PCF Congress!
- Join us live to take advantage of numerous interpersonal networking opportunities with colleagues and educational opportunities at our robust exhibit hall with our industry partners
- An invitation-only, closed-door Chief Compliance Officer (CCO) Roundtable on the morning of Tuesday, October 25
For more information contact pcf.org.info@gmail.com.
- Annual reports and updates provided by DOJ, FDA, and OIG
- Over 30 current topics addressing crucial ethics, compliance and legal issues
- An industry-only, closed-door session for pharma and device ethics, compliance and legal professionals on Wednesday, October 26
KEYNOTE SPEAKERS

Thomas Corcoran, JD
Assistant US Attorney, District of Maryland, US Department of Justice, Baltimore, MD

Charlene Keller Fullmer, JD
Assistant United States Attorney; Deputy Chief, Affirmative Litigation; US Attorney’s Office for the Eastern District of Pennsylvania, Philadelphia, PA

Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD

Mary A. Inman, JD
Whistleblower Counsel; Partner, Constantine, San Francisco, CA and London, UK

Lauren (Muldoon) Kootman, JD
Assistant Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

Kelly Begg Lawrence, JD
Assistant US Attorney & Chief, Health Care Fraud, District of Massachusetts, US Department of Justice, Boston, MA

Glenn Leon, JD
Fraud Section Chief, Criminal Division, US Department of Justice; Former SVP & Chief Ethics & Compliance Officer, Hewlett Packard Enterprise (HPE), Washington, DC

Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC

Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC

Jamie Yavelberg, JD
Director, Fraud Section, Civil Division, US Department of Justice, Washington, DC
FEATURED FACULTY

Khelin N. Aiken, JD
Partner, North America FDA Practice, Baker McKenzie; Former Regulatory Counsel, FDA

Punkaj T. Amin, MBA, CFE
Compliance Officer, Global Wound Management, Smith & Nephew

Madelyn Archibald
Compliance Specialist, Bioventus

Meredith S. Auten, JD
Partner, Morgan, Lewis & Bockius LLP

Richard Bagger, JD
Partner and Executive Director, Christie 55 Solutions LLC

Kristiana Bankova, MS
Senior Manager, Forensics & Integrity Services, EY

Eric M. Baim, MA, JD
Partner, Dovetail Consulting Group LLC; Former VP Compliance US, Shire

Rachel Batykefer
Senior Director, Integrity & Compliance CIA Operations, Mallinckrodt

Ann E. Beasley, JD
Vice President and Chief Compliance Officer, Zai Lab

Allison Benkert, MBA
Director Global Compliance Investigations, Seagen

Joshua Blank, JD
Senior Attorney, Arnold & Porter

Eric Bolesh
Chief Operating Officer, Cutting Edge Information

Ryan Bonistalli, JD
Senior Director, Compliance, Ultragenyx Pharmaceutical

Amy B. Boring, JD
Partner, King & Spalding LLP

Keysha Bradford
Director of Compliance, Amplity Health

Adam L. Braverman, JD
Partner, Morrison & Foerster, Former US Attorney, Southern District of California

Eve M. Brunts, LLM, JD
Partner, Ropes & Gray

Terra Buckley, JD
Vice President, Head of Compliance Advisory Services, MedPro Systems

Tim Canonico
Principal, Pharmaceutical & Life Sciences, Risk & Regulatory Leader, PwC

Craig Carpenito, JD
Partner, King & Spalding; Former US Attorney, New Jersey

Cynthia Cetani, LPEC
Chief Integrity & Compliance Officer, Indivior

Cheryl Chamallas
Vice President, Head of US Compliance, argenx

Masha Chestukhin, MSJ
Associate Director, Compliance Officer R&D, IA, FMV, Sanofi Genzyme

Shoshanna Clark, JD
Head of USBU Ethics & Compliance Operations, Takeda

Steven Cohen, MBA
Associate Vice President & Chief Ethics and Compliance Officer, North America and Canada, Eli Lilly

Chris Corallo
Compliance Officer, North America, Convatec

Zachary Coseglia, JD
Managing Principal & Head of Innovation, R&G Insights Lab, Ropes & Gray

Clarissa Crain
Managing Director, Deloitte & Touche LLP

David W. Cromley, JD
Associate Vice President, Global Compliance Organization, Merck

Tiffany Cummings-Damiani, MBA
Vice President and Head of Global Compliance, Insmed Incorporated

Donna Daniels, JD
Managing Director, Forensic & Integrity Services, EY

Meenakshi Datta, JD
Partner & Global Co-leader, Healthcare Practice, Sidley Austin

Mahnu V. Davar, MA, JD
Partner, Arnold & Porter

BJ D’Avella, MBA
Life Sciences Consulting Group Leader, Paul Hastings

James M. Dawson
Vice President, Compliance Solutions, Qordata

Jake DeBoever, JD
Vice President, Chief Compliance Officer, Dermavant Sciences

Chris DePhillips, JD
Senior Vice President, Chief Operating Officer and General Counsel, Porzio Life Sciences

Stefanie A. Doebler, JD
Partner and Co-chair, Health Care Practice Group, Covington & Burling LLP

Avia M. Dunn, JD
Partner, Skadden, Arps, Slate, Meagher & Flom LLP

Gildas Durand
Principal, Forensic & Integrity Services, EY

David Falcone
Associate Vice President Global Compliance, Merz Aesthetics

J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US
Managing Director, Epsilon Life Sciences LLC

Nicole L. Felician, JD
Executive Director, Legal Regulatory, Digital Health, Patient Centricity, Cell Therapies, Astellas Pharma US

Margaret K. Feltz, MA, JD
Vice President, Ethics and Compliance, Chief Compliance Officer, Purdue Pharma LP

Kellie Fidler, MBA, PMP
Senior Director, Compliance Risk Assessment, Monitoring and Operations, Bristol-Myers Squibb

Melissa Fitzgerald, JD
Privacy Officer, Olympus Corporation of the Americas

Christopher Fletchall, MBA
Vice President, G & M Health LLC

Bethany Fox, JD
Vice President, Commercial Legal Affairs, Exelixis

Sara Frank, JD
Principal, Choate, Hall & Stewart LLP

Sarah A. Franklin, JD
Partner and Vice-chair, Life Sciences Litigation and Investigations Practice Group, Covington & Burling LLP

Cari A. Gallman, JD
Senior Vice President, Chief Compliance and Ethics Officer, Bristol Myers Squibb

Nereyda Garcia, JD
Head, Ethics & Compliance, US Business Unit, Takeda

Gary F. Giampetruzzi, JD
Partner, Paul Hastings

Tara K. Giunta, JD
Partner, Paul Hastings

Edward P. Glynn, MBA
Principal, Forensic & Integrity Services, EY

Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, USDOJ

Tom Gregory, MBA, CPA
Partner, Forensic & Integrity Services, EY

Noor Haq, MBA, MS, CCEP
Executive Director, US Compliance, Amgen

Beth Hardcastle, JD
Partner, Sidley Austin LLP

Judith Haron, JD
Assistant General Counsel, PhRMA; Former Acting Chief Counsel, HHS

Todd Haugh, JD
Associate Professor of Business Law and Ethics, Kelley School of Business, Indiana University

Saul B. Helman MD, MBA
President, Epsilon Life Sciences

Kevin Henley, JD
Vice President, US Chief Compliance Officer, Otsuka America Pharmaceutical, Inc

Michael Hercz, JD
Senior Vice President & General Counsel, Sentynl

Emily F. Hodge, JD
Partner, Choate, Hall & Stewart LLP

Denis Jacob
Managing Director, Risk & Regulatory, PwC

Brenna E. Jenny, JD
Partner, Sidley

Abe Kassis, MBA, PhD
Senior Director, Global Head of Compliance and Legal Operations, Bausch + Lomb

Jeffrey Kawalek, MBA
Former Deputy, Chief Compliance Officer, Jazz Pharmaceuticals

Andrea Kocharyan, JD
Vice President, Head of Legal and Compliance, Zealand Pharma

Daniel Koerner
Senior Director, Potomac River Partners

Kirt Kraeuter, MGA
Senior Director, Corporate Compliance, Moderna

JJ Kuhn, JD
Vice President, Chief Counsel, Global Investigations, Medtronic

Stephanie Kurteff, JD, HCCP
Head of Compliance, Healthcare Compliance Officer, Medicines360

Rebekah Latchis, JD
Senior Director, Americas Office of Ethics and Compliance, Medtronic